C07D 515/06
Peri-condensed systems
C07D515/06 (Peri-condensed systems) appears on 7 US grants and 5 published applications in this corpus.
Search patents in C07D- Granted patents
- 7
- Published applications
- 5
- Assignees
- 6
- Inventors
- 31
- Latest grant
- 28 Sep 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 2 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 1 | 1 |
| 2017 | 1 | 0 |
| 2018 | 1 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 1 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Spiro-sulfonamide derivatives as inhibitors of myeloid cell leukemia-1 (MCL-1) protein28 Sep 2021US 11,130,769 B2Prelude Therapeutics Incorporated
- Conformationally constrained, fully synthetic macrocyclic compounds10 Jul 2018US 10,017,481 B2Polyphor AG
- General catalyst for C-H functionalization26 Sep 2017US 9,770,711 B2The Board of Trustees of the University of Illinois
- Cyclic amides22 Mar 2016US 9,290,467 B2Hoffmann-La Roche Inc.
- Heterocyclic pentalene derivatives for use in combating microorganisms12 Apr 1988US 4,737,507 AE. I. Du Pont de Nemours and Company
- Spiro-Sulfonamide Derivatives As Inhibitors Of Myeloid Cell Leukemia-1 (MCL-1) Protein12 Jan 2023US 2023/0010358 A1Prelude Therapeutics Incorporated
- Spiro-Sulfonamide Derivatives As Inhibitors Of Myeloid Cell Leukemia-1 (MCL-1) Protein14 May 2020US 2020/0148705 A1Prelude Therapeutics Incorporated
- General catalyst for c-h functionalization22 Sep 2016US 2016/0272662 A1The Board of Trustees of the University of Illinois
- Conformationally constrained, fully synthetic macrocyclic compounds19 Feb 2015US 2015/0051183 A1Polyphor AG
- Cyclic amides1 Aug 2013US 2013/0196965 A1Hoffmann-La Roche Inc.
Most cited
By later US patents
- Conformationally constrained, fully synthetic macrocyclic compounds7US 10,017,481 B2Polyphor AG · 2018
- Herbicidal heterocyclic pentalenes2US 4,441,911 AShell Oil Company · 1984
- General catalyst for C-H functionalization2US 9,770,711 B2The Board of Trustees of the University of Illinois · 2017
- Heterocyclic pentalenes as herbicides1US 4,440,564 AShell Oil Company · 1984
- Heterocyclic pentalene derivatives for use in combating microorganisms1US 4,737,507 AE. I. Du Pont de Nemours and Company · 1988